Transthyretin asn90 variant: Amyloidogenic or non-amyloidogenic role

[1]  A. Hofman,et al.  Prevalence and risk factors of cerebral microbleeds , 2008, Neurology.

[2]  T. Joensuu,et al.  Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients , 2007, European Journal of Human Genetics.

[3]  C. Sudlow,et al.  Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. , 2006, Stroke.

[4]  Masaaki Nakamura,et al.  Transthyretin-related familial amyloidotic polyneuropathy. , 2005, Archives of neurology.

[5]  M. Yamada.  Cerebral amyloid angiopathy and gene polymorphisms , 2004, Journal of the Neurological Sciences.

[6]  Catherine E Costello,et al.  Tabulation of human transthyretin (TTR) variants, 2003 , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[7]  M. Saraiva.  Transthyretin mutations in hyperthyroxinemia and amyloid diseases , 2001, Human mutation.

[8]  M. Mascalchi,et al.  Transthyretin amyloidosis and superficial siderosis of the CNS. , 1999, Neurology.

[9]  R. Falk,et al.  The systemic amyloidoses. , 1997, The New England journal of medicine.

[10]  R. Petersen,et al.  Transthyretin amyloidosis: A new mutation associated with dementia , 1997, Annals of neurology.

[11]  N. Bresolin,et al.  The apolipoprotein E ϵ4 allele causes a faster decline of cognitive performances in Down's syndrome subjects , 1997, Journal of the Neurological Sciences.

[12]  H. Budka,et al.  Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly) , 1996, Neurology.

[13]  M. Benson.  Leptomeningeal amyloid and variant transthyretins. , 1996, The American journal of pathology.

[14]  H. Budka,et al.  Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) , 1996, The American journal of pathology.

[15]  M. Skinner,et al.  Two transthyretin mutations (glu42gly, his90asn) in an Italian family with amyloidosis , 1994, Clinical genetics.

[16]  Y. Sakaki,et al.  Amyloidogenic and non‐amyloidogenic transthyretin Asn 90 variants , 1992, Clinical genetics.

[17]  M. R. Almeida,et al.  Molecular analyses of an acidic transthyretin Asn 90 variant. , 1991, American journal of human genetics.

[18]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[19]  J. Milunsky,et al.  A new transthyretin variant from a patient with familial amyloidotic polyneuropathy has asparagine substituted for histidine at position 90 , 1991, Clinical genetics.

[20]  M. Skinner,et al.  A new mutation causing familial amyloidotic polyneuropathy. , 1989, Biochemical and biophysical research communications.

[21]  N. Yanagisawa,et al.  Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy , 2004, Acta Neuropathologica.

[22]  N. Schormann,et al.  Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.